Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
about
Emerging drugs for uveitisCyclosporine for ocular inflammatory diseases.Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.Role of oxygen free radicals in retinal damage associated with experimental uveitisBromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.Systemic therapies for inflammatory eye disease: past, present and futureAmelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.Bench to bedside: new approaches to the immunotherapy of uveitic disease.Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patientsPrevention of diabetes mellitus in the BB/W rat with Cyclosporin-ABeta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.Endogenous posterior uveitis.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Effects of cyclosporine in spontaneous, posterior uveitis.Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?Immunotolerance and prevention of ocular autoimmune disease.Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report.Immunotherapy for Behçet's disease.A comparative approach to topical cyclosporine therapy.Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin ALow dose cyclosporin A therapy in chronic posterior uveitis.Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation.Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide.Sandimmun(®) (ciclosporin, Cyclosporin A) Past experience and present uses in autoimmune diseases.Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection
P2860
Q24630848-C9B5E53A-5132-46F7-85FF-3EF396403A03Q33520584-FA7BA37C-F52A-404A-BE2F-144BDF345F1CQ33760317-1A49C8CD-B599-46F2-B0A3-0B378D06CD94Q34164506-AB3A26D2-6D99-412C-9D2F-E3A99644F81BQ34566842-79283DBB-30E4-47F5-B12C-EAF27685055FQ34687332-F8E4095C-D1A8-4AAF-AF42-E551AEE4C824Q34692643-DE715F5C-2F15-49BC-BB57-CDE81BE529EDQ34993229-0CF82EC8-A1B5-4667-8A6D-12D7443CC6A0Q35298191-EEC45134-D49F-41C6-822E-4C789E554D2EQ35582940-392DE67E-016D-417D-A80F-28AA1708D971Q35858507-4D172EB5-2BBD-4053-A379-09680E22BE2AQ36232654-CA54C69E-460E-462A-82BC-AAB13E0DC6A3Q37262587-E1A5D0B1-FD18-4B3E-8742-FC1B780E4B10Q37361237-0DFC8F5B-2E27-4CD3-A5D1-3C255155E010Q38031601-01DA64BF-3FF1-4BC3-98CA-5DA5AB4F6B95Q38168361-534F994B-1C02-4C0C-9D9F-4AD8A1792BDCQ38477174-F22098FC-28A7-4C23-B1FF-77E4E03700D1Q39693140-977642B2-A0B6-4919-AA41-0D9B794F5AD0Q39706642-02547056-47A1-4C57-88DC-7CD67FCA16D0Q40909960-170156AA-D814-481E-A352-25CCC717236AQ40927838-1CAD25F4-BC10-4D3A-A6C5-C9E78B2142A9Q40976391-30B3CC3B-AE22-48B6-A044-2BF551A76331Q41514354-C899EB72-DEA7-43B1-BA85-43CA0A61F23BQ41678598-4F945793-262C-4D19-87F4-E7BF0ADFEC68Q41719098-61C00602-81D9-4285-B313-68107D4AE86FQ44276629-30CBC6AA-8CF0-4B59-AE6B-DE0D868A2BA6Q44621307-7EDD8BB0-C54D-4276-8E35-463D64B1EC0AQ44744832-15FC1278-AB5A-43E1-9E3F-F9AD7088F2C6Q54249875-7DF716A0-7A94-4401-8572-192413FAFCE9Q57281016-6E2B0ECE-6A69-4331-9CA2-72688DB56C3A
P2860
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
@en
type
label
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
@en
prefLabel
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
@en
P2093
P2860
P356
P1476
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
@en
P2093
Cevario SJ
Nussenblatt RB
Rodrigues MM
Salinas-Carmona MC
P2860
P304
P356
10.1172/JCI110138
P407
P577
1981-04-01T00:00:00Z